Connect
← Return to Bone turnover markers (CTX and P1NP): do you have a baseline?
Discussion
Bone turnover markers (CTX and P1NP): do you have a baseline?
Osteoporosis & Bone Health | Last Active: Sep 20 11:58am | Replies (240)Comment receiving replies
Mike,
I was on Evenity for one year T score in spine -4.6 . Then after one year T score -3.3. Then I was put on Prolia and after one year T score 3.2. My endocrinologist now suggest Reclast basically no change. Can you please give me your insight on switching at this time to reclast ?
Replies to "Mike, I was on Evenity for one year T score in spine -4.6 . Then after..."
I would be interested too Mike. Thanks
Connect
Deciding what to do during a med transition is always tricky. This graph might be useful. It’s from the FRAME Extension study: 1 year of romosozumab followed by 2 years of denosumab, and it shows the average bmd % increase after 1 and 2 years of denosumab.